Home > Boards > US Listed > Medical - Equipment >

Cytosorbents Corporation (CTSO)

Add CTSO Price Alert      Hide Sticky   Hide Intro
Moderator: orangecat, dah174174, caesare74, Good Sport
Search This Board: 
Last Post: 5/25/2019 11:03:23 AM - Followers: 212 - Board type: Free - Posts Today: 1

CytoSorbents Corporation is a leader in critical care immunotherapy, specializing in blood purification. Its flagship product, CytoSorb® is approved in the European Union with distribution in 45 countries around the world, as an extracorporeal cytokine adsorber designed to reduce the "cytokine storm" or "cytokine release syndrome" that could otherwise cause massive inflammation, organ failure and death in common critical illnesses. These are conditions where the risk of death is extremely high, yet no effective treatments exist. CytoSorb® is also being used during and after cardiac surgery to remove inflammatory mediators that can lead to post-operative complications, including multiple organ failure. CytoSorbents recently initiated its pivotal REFRESH (REduction in FREe Hemoglobin) 2 trial – a multi-center, randomized controlled, clinical trial intended to support U.S. regulatory approval of CytoSorb for use in a heart-lung machine during complex cardiac surgery to reduce organ injury. CytoSorb® has been used in more than 46,000 human treatments to date. 

CytoSorbents' purification technologies are based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Its technologies have received non-dilutive grant, contract, and other funding of nearly $22 million from DARPA, the U.S. Army, the U.S. Department of Health and Human Services, the National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), U.S. Special Operations Command (SOCOM) and others. The Company has numerous products under development based upon this unique blood purification technology, protected by 32 issued U.S. patents and multiple applications pending, including CytoSorb-XL™, HemoDefend™, VetResQ™, K+ontrol™, ContrastSorb, DrugSorb, and others. For more information, please visit the Company's websites at http://www.cytosorbents.com and http://www.cytosorb.com or follow us on Facebook and Twitter.

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CTSO News: Statement of Changes in Beneficial Ownership (4) 05/14/2019 03:30:27 PM
CTSO News: Current Report Filing (8-k) 05/08/2019 06:34:32 AM
CTSO News: Quarterly Report (10-q) 05/07/2019 04:30:46 PM
CTSO News: Additional Proxy Soliciting Materials (definitive) (defa14a) 04/22/2019 08:06:46 AM
CTSO News: Proxy Statement (definitive) (def 14a) 04/22/2019 08:02:10 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#16383   We are ahead in the game.Looking to finally berthabluefish1 05/25/19 11:03:23 AM
#16377   2 new locations added for REFRESH - now Canes16 05/24/19 10:23:43 AM
#16376   Someone pinch me. Did this POS open green today? ssmmss 05/24/19 09:36:13 AM
#16375   slappie, I see down two days in a biotech48 05/23/19 03:50:17 PM
#16374   Bio 2 days in a row now. slappie 05/23/19 03:39:44 PM
#16373   Orangecat, imo, CTSO & Fresenius renegotiated their distributer Burnttoast247 05/23/19 11:38:57 AM
#16372   slappie, you are changing the subject, which was biotech48 05/23/19 11:07:00 AM
#16371   He did specifically used the terms "take back" orangecat 05/23/19 10:32:46 AM
#16370   So Slap'ster…. You have experience with HadToHavit 05/23/19 09:57:21 AM
#16369   You don't think 80% of news is about slappie 05/23/19 07:37:08 AM
#16368   Raptorjockey & Orangecat SAME POINT I have been Burnttoast247 05/23/19 12:06:51 AM
#16367   Orangecat, I don't believe Fresenius has left the raptorjockey 05/22/19 05:33:30 PM
#16366   slappie, you surely cannot truly believe that share biotech48 05/22/19 05:23:57 PM
#16365   PPS red since announcement of vacation. Like other slappie 05/22/19 04:19:53 PM
#16364   I think there was some better color on orangecat 05/22/19 01:41:49 PM
#16363   Ridiculous comment, as usual. hemopure36 05/22/19 12:14:16 PM
#16362   Genius Chan must not have impressed anyone. ssmmss 05/22/19 12:03:57 PM
#16361   Sounded like first data from CRS Cart T berthabluefish1 05/22/19 12:00:42 PM
#16360   Good Q & A AT END OF presentation Burnttoast247 05/22/19 11:34:52 AM
#16359   Another paid trip to California. Collecting Air Miles mikesmith999945 05/22/19 11:25:13 AM
#16358   what can you say DR CHAN at conference Burnttoast247 05/22/19 10:47:04 AM
#16357   Case of the Week andy55q 05/22/19 08:21:33 AM
#16356   https://pro.allianceforhealth.net/p/AAH_klebsi1yr_1118/LAAHV536/Full?h=true Burnttoast247 05/21/19 08:56:13 PM
#16355   The moderators should be protecting the integrity of Jacquescode 05/21/19 07:16:12 PM
#16354   Agree Lakersback enough already thought you sold ? Burnttoast247 05/21/19 05:35:01 PM
#16353   ENOUGH ON EDTXF! and medical circles you dah174174 05/21/19 01:16:13 PM
#16352   lakersrback, please stop your constant pumping of EDTXF biotech48 05/21/19 11:55:08 AM
#16351   MYSTIFYING WHY CTSO REMAINS UNDER $10/$12 PPS for Burnttoast247 05/21/19 11:36:47 AM
#16350   ssmmss You had at least HadToHavit 05/21/19 11:17:45 AM
#16349   CEOs who know how to make money for ssmmss 05/21/19 10:56:57 AM
#16348  Restored Sepsis graveyard indeed...in more ways than one. Lakersrback 05/21/19 10:42:41 AM
#16347   Sepsis has been termed a pharmaceutical graveyard berthabluefish1 05/21/19 09:29:58 AM
#16346   You realize that reading this quickly/not carefully could fantomphan 05/21/19 08:42:18 AM
#16345   Bertha, IMO, What a sad waste OF TIME, Burnttoast247 05/21/19 12:31:30 AM
#16344   Sepsis Treatment Flops in Phase 3 Trial.Thrombomodulin did berthabluefish1 05/20/19 10:01:34 PM
#16343   raptorjockey - The point of my most recent BG Man 05/20/19 06:09:57 PM
#16342   BG, After reading your post, I realize there raptorjockey 05/20/19 05:43:04 PM
#16341   CMS delays payment decision for CAR T-cell therapy BG Man 05/20/19 12:48:08 PM
#16340   https://immuno-oncologynews.com/2019/05/14/cirm-grant-phase-1-trial-new-immunoth Burnttoast247 05/20/19 10:24:39 AM
#16339   Agreed slappie 05/20/19 10:08:54 AM
#16338   A real Terd investor... sell. Move on. HadToHavit 05/20/19 09:30:15 AM
#16337   Lets all pray Dr Chan updates his very Burnttoast247 05/20/19 09:26:29 AM
#16336   Ridiculous comment, as usual. hemopure36 05/20/19 09:03:53 AM
#16335   Another nice vacation for chanie at SH expense coldterdinvestor 05/20/19 09:02:57 AM
#16334   NEWS -- CytoSorbents to Participate at the B. Paulness 05/20/19 08:29:34 AM
#16333   Chan said they were working with major players berthabluefish1 05/18/19 08:03:23 PM
#16332   At this point I would have thought that firefighter2830 05/18/19 07:00:25 PM
#16331   More likely is a partnership with one of hemopure36 05/18/19 05:42:54 PM
#16330   Maybe Cytosorb could pay for a few CAR firefighter2830 05/18/19 05:04:40 PM
#16329   That doesn't make someone a crook, I would biotech48 05/18/19 02:59:40 PM